Dataset for Bibliometric Analysis of Orodispersible Films (2014-2025)

Medicines play an essential role in promoting health and improving both life expectancy and quality of life. However, traditional oral administration poses limitations for certain patient groups, underscoring the need for patient-centered therapeutic approaches and personalized medicine strategies. In this context, orodispersible films (ODFs) emerge as a promising alternative to conventional tablets and capsules, offering advantages such as greater comfort, acceptability, ease of swallowing, dosing precision, low thickness, and flexibility. Nevertheless, significant knowledge gaps remain, necessitating a focused bibliometric analysis. Therefore, this study aimed to conduct a bibliometric analysis utilizing performance analysis (annual scientific production, geographical distribution, key journals, and productive authors), science mapping (co-authorship, keyword co-occurrence, and co-citation networks), and enrichment techniques (thematic maps, trend topics, and factorial analysis). A systematic search of the Scopus database (2014–2025) yielded a final sample of 467 documents, which were analyzed using Bibliometrix and VOSviewer. Results indicate oscillatory growth, with peaks in 2018 and 2022 associated with cycles of technological innovation. Geographical distribution reveals a contrast between the leadership of Asia (India and China) and Europe (Germany), where key authors such as J. Breitkreutz and F. Cilurzo serve as central references. Knowledge dissemination is concentrated in pharmaceutical technology journals (e.g., Int. J. Pharm. and Pharmaceutics), reflecting the field's engineering bias. A connection was identified between polymer formulation and personalized medicine. Finally, advanced visualization analyses confirm the thematic evolution from solvent casting to 3D printing and nanofibers. It is concluded that orodispersible films have evolved from a convenience pharmaceutical dosage form to established strategic platforms in precision medicine. While this evolution is driven by technological advancement, it faces the critical challenge of integrating materials engineering innovations with regulatory standardization and the clinical evidence required for widespread therapeutic implementation. This study was financed by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Social Demand Program (DS) - Finance Code 001.